| Mitochondrial dysfunction in Parkinson's disease PC Keane, M Kurzawa, PG Blain, CM Morris Parkinson’s disease 2011, 2011 | 186 | 2011 |
| Severe clinical toxicity associated with analytically confirmed recreational use of 25I–NBOMe: case series SL Hill, TOM Doris, S Gurung, S Katebe, A Lomas, M Dunn, P Blain, ... Clinical Toxicology 51 (6), 487-492, 2013 | 174 | 2013 |
| Steady-state pharmacokinetics of phenytoin from routinely collected patient data TH Grasela, LB Sheiner, B Rambeck, HE Boenigk, A Dunlop, PW Mullen, ... Clinical pharmacokinetics 8, 355-364, 1983 | 157 | 1983 |
| The clinical implications of elevated blood metal ion concentrations in asymptomatic patients with MoM hip resurfacings: a cohort study DJ Langton, RP Sidaginamale, TJ Joyce, S Natu, P Blain, RD Jefferson, ... BMJ open 3 (3), e001541, 2013 | 116 | 2013 |
| Blood metal ion testing is an effective screening tool to identify poorly performing metal-on-metal bearing surfaces RP Sidaginamale, TJ Joyce, JK Lord, R Jefferson, PG Blain, AVF Nargol, ... Bone & joint research 2 (5), 84-95, 2013 | 114 | 2013 |
| Tear gases and irritant incapacitants: 1-chloroacetophenone, 2-chlorobenzylidene malononitrile and dibenz [b, f]-1, 4-oxazepine PG Blain Toxicological reviews 22, 103-110, 2003 | 114 | 2003 |
| Nature and role of xenobiotic metabolizing esterases in rat liver, lung, skin and blood NW McCracken, PG Blain, FM Williams Biochemical pharmacology 45 (1), 31-36, 1993 | 109 | 1993 |
| The pharmacokinetics of single doses of metoclopramide in renal failure DN Bateman, R Gokal, TRP Dodd, PG Blain European journal of clinical pharmacology 19, 437-441, 1981 | 105 | 1981 |
| Occupational hazard in hospital staff exposed to 2 per cent glutaraldehyde in an endoscopy unit SJ Jachuck, CL Bound, J Steel, PG Blain Occupational Medicine 39 (2), 69-71, 1989 | 99 | 1989 |
| Haloperidol secreted in breast milk. LJ Whalley, PG Blain, JK Prime Br Med J (Clin Res Ed) 282 (6278), 1746-1747, 1981 | 97 | 1981 |
| Tartrazine and sunset yellow are xenoestrogens in a new screening assay to identify modulators of human oestrogen receptor transcriptional activity A Axon, FEB May, LE Gaughan, FM Williams, PG Blain, MC Wright Toxicology 298 (1-3), 40-51, 2012 | 86 | 2012 |
| Interindividual variations in enzymes controlling organophosphate toxicity in man E Mutch, PG Blain, FM Williams Human & experimental toxicology 11 (2), 109-116, 1992 | 84 | 1992 |
| Determinants of plasma alpha 1‐acid glycoprotein (AAG) concentrations in health. PG Blain, JC Mucklow, MD Rawlins, DF Roberts, PA Routledge, ... British journal of clinical pharmacology 20 (5), 500-502, 1985 | 84 | 1985 |
| Pharmacokinetics and clinical toxicity of quinine overdosage: lack of efficacy of techniques intended to enhance elimination DN Bateman, PG Blain, KW Woodhouse, MD Rawlins, H Dyson, ... QJM: An International Journal of Medicine 54 (2), 125-131, 1985 | 84 | 1985 |
| The role of metabolism in determining susceptibility to parathion toxicity in man E Mutch, PG Blain, FM Williams Toxicology letters 107 (1-3), 177-187, 1999 | 81 | 1999 |
| Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations AA Khundakar, PS Hanson, D Erskine, NZ Lax, J Roscamp, E Karyka, ... Acta neuropathologica communications 4, 1-18, 2016 | 77 | 2016 |
| Glucocerebrosidase mutations alter the endoplasmic reticulum and lysosomes in Lewy body disease M Kurzawa‐Akanbi, PS Hanson, PG Blain, DJ Lett, IG McKeith, ... Journal of neurochemistry 123 (2), 298-309, 2012 | 74 | 2012 |
| Organophosphorus poisoning (acute) PG Blain BMJ clinical evidence 2011, 2011 | 70 | 2011 |
| DNA damage, signalling and repair after exposure of cells to the sulphur mustard analogue 2-chloroethyl ethyl sulphide PA Jowsey, FM Williams, PG Blain Toxicology 257 (3), 105-112, 2009 | 70 | 2009 |
| The percutaneous absorption and skin distribution of lindane in man: I. in vivo studies IP Dick, PG Blain, FM Williams Human & experimental toxicology 16 (11), 645-651, 1997 | 68 | 1997 |
